Past Studies

1996 PROTECT, Bayer, Phase 4 

2000 Humalog Mix 75/25, Eli Lilly, Phase 4 

2002-2005 Amigo 115, Amylin, Phase 3 

2003-2005 pramlitide, Amylin, Phase 3 

2003-2004 GOT, Aventis, Phase 4 

2004 Siriani, Phase 4 

2004-2006 Apidra, Aventis, Phase 4 

2004-2005 NovoNordisk ANA2190, Phase 4 

2005 Initiate Plus, NovoNordisk, Phase 4 

2004-2006, Reach Registry 

2006-2008, IOOV, Eli Lilly, Phase 4 

2007 Symlin Observational Study, Amylin, Phase 4 

2007 [S,S]Reboxetine-DPN,, Pfizer, Phase 2b

2007 Exenatide Obsevational Study, Eli Lilly, Phase 4 

2009-2010 LACE Lantus/Levemir Retrospective Chart Review 

2009-2010 LACE Lantus/Byetta 

2010 TIMI SAVOR-53 Phase 4 

2010 EXCEL, Amylin, Phase 3 

2011 MOSA1c, Eli Lilly, Phase 4 

2011 ANSWER Registry, NovoNordisk 

2014-2018 NovoNordisk NN8640-4050, Phase 3 

2015-2018 DEPICT 2, Bristol Myers Squibb, MB102-230, Phase 3 2015-2018 LPS14347, Sanofi, Phase 4 

2017 Sentier 401 Registry 

2018-2019 Shire 404 Phase 3 

2019 Mylan Gazelle phase 3 

2022-Corcept Grace phase 3